GB647925A - Improvements relating to the extraction and purification of an antibiotic - Google Patents

Improvements relating to the extraction and purification of an antibiotic

Info

Publication number
GB647925A
GB647925A GB13569/48A GB1356948A GB647925A GB 647925 A GB647925 A GB 647925A GB 13569/48 A GB13569/48 A GB 13569/48A GB 1356948 A GB1356948 A GB 1356948A GB 647925 A GB647925 A GB 647925A
Authority
GB
United Kingdom
Prior art keywords
polymyxin
alcohol
sulphate
sulphated
lauryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB13569/48A
Inventor
Clifford George Pope
Walter Mark Duffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB13569/48A priority Critical patent/GB647925A/en
Publication of GB647925A publication Critical patent/GB647925A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides

Abstract

Polymyxin is recovered from a metabolism fluid containing it by treating such fluid, after removal of bacterial cells and any gummy impurities therefrom, at a pH of 4-8 (preferably about 4.5) with one or more sulphated fatty alcohols or esters or a salt or mixture of salts thereof (e.g. a mixture of the sodium salts of sulphated olefines containing 10-18 carbon atoms, the sodium and triethanolamine salts of sulphated lauryl alcohol, sodium dioctyl sulphosuccinate, lauryl sulphate, or a mixture of cetyl and oleyl sulphates). The resulting precipitate is separated by filtration, centrifuging or gravity and freed from water, after which the active fraction thereof may be extracted with a solvent therefor (e.g. methyl, ethyl, n- or iso-propyl, n- or iso-butyl or lauryl alcohol). The polymyxin may be recovered from an ethyl alcohol extract by one of the following methods: (a) the alcohol is evaporated and the residue dissolved in water with the aid of a strong organic base (e.g. benzylamine or cyclohexylamine) with simultaneous addition of sulphuric acid to keep the pH below 9.5, then more sulphuric acid is added to bring the pH to about 2-3, the resulting complex of alkyl sulphate and organic base is extracted with a water-immiscible alcohol (e.g. butyl alcohol), and polymyxin sulphate is recovered from the aqueous phase by freeze-drying; (b) an isopropyl alcohol solution of the polymyxin-alkyl sulphate complex is treated with an isopropyl alcohol solution of a sulphate of a strong organic base to precipitate polymyxin sulphate, or with dry hydrogen chloride to precipitate polymyxin hydrochloride; (c) the ethyl alcohol extract is decomposed with hydrochloric acid, and the solution is poured into excess of acetone to precipitate the polymyxin. The product may be further purified by treatment with activated charcoal or fractional precipitation. According to the Provisional Specification, the process is also applicable to the recovery of other antibiotics of basic nature, such as streptomycin. A further method of recovering polymyxin sulphate from the complex is also described therein. Specification 619,572 is referred to.ALSO:A therapeutic material is prepared by mixing a solution of a salt or complex of polymyxin and a sulphated fatty alcohol or ester with a vehicle such as arachis oil and removing the solvent to leave a suspension of the polymyxin complex in the vehicle. Specified sulphated fatty compounds are sodium and triethanolamine salts of sulphated lauryl alcohol, sodium dioctyl sulphosuccinate, lauryl sulphate, a mixture of cetyl and aleyl sulphates and the sodium salts of sulphated olefins containing 10 to 18 carbon atoms. Suitable solvents are methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl and lauryl alcohols. Specification 619,572 is referred to.
GB13569/48A 1948-05-19 1948-05-19 Improvements relating to the extraction and purification of an antibiotic Expired GB647925A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB13569/48A GB647925A (en) 1948-05-19 1948-05-19 Improvements relating to the extraction and purification of an antibiotic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13569/48A GB647925A (en) 1948-05-19 1948-05-19 Improvements relating to the extraction and purification of an antibiotic

Publications (1)

Publication Number Publication Date
GB647925A true GB647925A (en) 1950-12-28

Family

ID=10025333

Family Applications (1)

Application Number Title Priority Date Filing Date
GB13569/48A Expired GB647925A (en) 1948-05-19 1948-05-19 Improvements relating to the extraction and purification of an antibiotic

Country Status (1)

Country Link
GB (1) GB647925A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413398A (en) * 1963-08-30 1968-11-26 Burroughs Wellcome Co Purification of polymyxin
WO2010058427A2 (en) 2008-11-24 2010-05-27 Reliance Life Sciences Pvt. Ltd. Process for production and purification of polymyxin b sulfate
CN109512999A (en) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 The application of synergetic effect additive of the fatty alcohol of oxygen-containing hydrocarbon derivative as polymyxins

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413398A (en) * 1963-08-30 1968-11-26 Burroughs Wellcome Co Purification of polymyxin
WO2010058427A2 (en) 2008-11-24 2010-05-27 Reliance Life Sciences Pvt. Ltd. Process for production and purification of polymyxin b sulfate
CN109512999A (en) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 The application of synergetic effect additive of the fatty alcohol of oxygen-containing hydrocarbon derivative as polymyxins

Similar Documents

Publication Publication Date Title
GB1210446A (en) Continuous process for the purification of phosphoric acid
US2989438A (en) Process of purifying heparin, and product produced therefrom
ES280082A1 (en) Process for the recovery of phosphoric acid from aqueous reaction mixtures produced by the decomposition of tricalcium phosphate with hydrochloric acid
GB2179337A (en) Process for purifying waste-waters
GB647925A (en) Improvements relating to the extraction and purification of an antibiotic
US4014994A (en) Process for the recovery and purification of partricin
US3919266A (en) Production of bile acids
US3928431A (en) Method of isolating L-dopa from a aqueous solution thereof
US2463943A (en) Production of penicillin salts
GB464370A (en) Improvements in and relating to processes for the purification of crude phosphoric acid
GB769239A (en) Process for separating tetracycline from chlortetracycline
Eagles Biochemistry of sulfur. II. The isolation of ergothioneine from ergot of rye
GB697007A (en) Improvements relating to the recovery of unsaponifiables from concentrates containing unsaponifiables admixed with saponified fatty materials
GB1240285A (en) Purification of phosphoric acid
US3376339A (en) Purification of amphoteric and basic antibiotics
US2005700A (en) Process of extracting sex hormones and a compound of a sex hormone with an alkaloid
US2578840A (en) Streptomycin purification
US1976175A (en) Process of preparing adenosine phosphoric acid
GB1233421A (en)
GB578590A (en) Improvements in or relating to the preparation of penicillin salts
GB872214A (en) Extraction process for the recovery of heparin
US2331574A (en) Process of recovering bilirubin
KR100312639B1 (en) Method for recovering tetrazole-1-acetate
US3442916A (en) Isolation of eburicoic acid
GB1453063A (en) Method for purifying 3,5-cyclic-adenylic acid or 3,5-cyclic- deoxy-adenylic acid